Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

INTRODUCTION: Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants and evidence regarding the best treatment approach is lacking. Currently available medical options to treat a PDA include indomethacin, ibuprofen or acetaminophen. Wide variation e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, Souvik, Jain, Amish, Ting, Joseph Y., Ben Fadel, Nadya, Drolet, Christine, Abou Mehrem, Ayman, Soraisham, Amuchou, Jasani, Bonny, Louis, Deepak, Lapointe, Anie, Dorling, Jon, Khurshid, Faiza, Hyderi, Abbas, Kumaran, Kumar, Bodani, Jaya, Weisz, Dany, Alvaro, Ruben, Adie, Mohammed, Stavel, Miroslav, Morin, Alyssa, Bhattacharya, Soume, Kanungo, Jaideep, Canning, Rody, Ye, Xiang Y, Hatfield, Tara, Gardner, Courtney E, Shah, Prakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103361/
https://www.ncbi.nlm.nih.gov/pubmed/33952559
http://dx.doi.org/10.1136/bmjopen-2021-050682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103361/
https://www.ncbi.nlm.nih.gov/pubmed/33952559
http://dx.doi.org/10.1136/bmjopen-2021-050682

Ejemplares similares